Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 122

Similar articles for PubMed (Select 22565165)

1.

Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.

Grover S, Gourie-Devi M, Bala K, Sharma S, Kukreti R.

Pharmacogenet Genomics. 2012 Jun;22(6):447-65. doi: 10.1097/FPC.0b013e3283528217.

PMID:
22565165
2.

ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.

Qu J, Zhou BT, Yin JY, Xu XJ, Zhao YC, Lei GH, Tang Q, Zhou HH, Liu ZQ.

CNS Neurosci Ther. 2012 Aug;18(8):647-51. doi: 10.1111/j.1755-5949.2012.00336.x. Epub 2012 May 28.

PMID:
22630058
3.

Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.

Ufer M, von Stülpnagel C, Muhle H, Haenisch S, Remmler C, Majed A, Plischke H, Stephani U, Kluger G, Cascorbi I.

Pharmacogenet Genomics. 2011 Oct;21(10):624-30. doi: 10.1097/FPC.0b013e3283498131.

PMID:
21799461
4.

Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.

Ufer M, Mosyagin I, Muhle H, Jacobsen T, Haenisch S, Häsler R, Faltraco F, Remmler C, von Spiczak S, Kroemer HK, Runge U, Boor R, Stephani U, Cascorbi I.

Pharmacogenet Genomics. 2009 May;19(5):353-62.

PMID:
19415824
5.

MRP2 haplotypes confer differential susceptibility to toxic liver injury.

Choi JH, Ahn BM, Yi J, Lee JH, Lee JH, Nam SW, Chon CY, Han KH, Ahn SH, Jang IJ, Cho JY, Suh Y, Cho MO, Lee JE, Kim KH, Lee MG.

Pharmacogenet Genomics. 2007 Jun;17(6):403-15.

PMID:
17502832
6.

A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.

Grover S, Kukreti R.

Epilepsia. 2013 May;54(5):936-45. doi: 10.1111/epi.12132. Epub 2013 Mar 18. Review.

PMID:
23506516
7.

Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy.

Sporis D, Bozina N, Basić S, Lovrić M, Babić T, Susak I, Marković I.

Coll Antropol. 2013 Mar;37(1):41-5.

PMID:
23697249
8.

Influence of polymorphisms of ABCB1 and ABCC2 on mRNA and protein expression in normal and cancerous kidney cortex.

Haenisch S, Zimmermann U, Dazert E, Wruck CJ, Dazert P, Siegmund W, Kroemer HK, Warzok RW, Cascorbi I.

Pharmacogenomics J. 2007 Feb;7(1):56-65. Epub 2006 Jun 20. Erratum in: Pharmacogenomics J. 2007 Feb;7(1):74. Siegmund, S [corrected to Siegmund, W].

PMID:
16788565
9.

Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.

Han JY, Lim HS, Yoo YK, Shin ES, Park YH, Lee SY, Lee JE, Lee DH, Kim HT, Lee JS.

Cancer. 2007 Jul 1;110(1):138-47. Erratum in: Cancer. 2010 Aug 1;116(15):3749.

10.

Influence of genetic polymorphisms on intestinal expression and rifampicin-type induction of ABCC2 and on bioavailability of talinolol.

Haenisch S, May K, Wegner D, Caliebe A, Cascorbi I, Siegmund W.

Pharmacogenet Genomics. 2008 Apr;18(4):357-65. doi: 10.1097/FPC.0b013e3282f974b7.

PMID:
18334920
11.

Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital.

Subenthiran S, Abdullah NR, Joseph JP, Muniandy PK, Mok BT, Kee CC, Ismail Z, Mohamed Z.

PLoS One. 2013 May 23;8(5):e64827. doi: 10.1371/journal.pone.0064827. Print 2013.

12.

Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.

Niemi M, Arnold KA, Backman JT, Pasanen MK, Gödtel-Armbrust U, Wojnowski L, Zanger UM, Neuvonen PJ, Eichelbaum M, Kivistö KT, Lang T.

Pharmacogenet Genomics. 2006 Nov;16(11):801-8.

PMID:
17047488
13.

Lack of association between ABCC2 gene variants and treatment response in epilepsy.

Hilger E, Reinthaler EM, Stogmann E, Hotzy C, Pataraia E, Baumgartner C, Zimprich A, Zimprich F.

Pharmacogenomics. 2012 Jan;13(2):185-90. doi: 10.2217/pgs.11.143.

PMID:
22256867
14.

Functional characterization of ABCC2 promoter polymorphisms and allele-specific expression.

Nguyen TD, Markova S, Liu W, Gow JM, Baldwin RM, Habashian M, Relling MV, Ratain MJ, Kroetz DL.

Pharmacogenomics J. 2013 Oct;13(5):396-402. doi: 10.1038/tpj.2012.20. Epub 2012 Jun 5.

15.

Impact of ABCC2 haplotypes on transcriptional and posttranscriptional gene regulation and function.

Laechelt S, Turrini E, Ruehmkorf A, Siegmund W, Cascorbi I, Haenisch S.

Pharmacogenomics J. 2011 Feb;11(1):25-34. doi: 10.1038/tpj.2010.20. Epub 2010 Mar 30.

PMID:
20351751
16.

ABCC2 haplotype is not associated with drug-resistant epilepsy.

Seo T, Ishitsu T, Oniki K, Abe T, Shuto T, Nakagawa K.

J Pharm Pharmacol. 2008 May;60(5):631-5. doi: 10.1211/jpp.60.5.0009.

PMID:
18416940
17.

ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.

Lazarowski A, Czornyj L, Lubienieki F, Girardi E, Vazquez S, D'Giano C.

Epilepsia. 2007;48 Suppl 5:140-9. Review. Erratum in: Epilepsia. 2007 Dec;48(12):2380.

PMID:
17910594
18.

Association of the multidrug-resistance-associated protein gene (ABCC2) variants with intrahepatic cholestasis of pregnancy.

Sookoian S, Castaño G, Burgueño A, Gianotti TF, Pirola CJ.

J Hepatol. 2008 Jan;48(1):125-32. Epub 2007 Oct 23.

PMID:
17997497
19.

Association of ATP-binding cassette, sub-family C, number 2 (ABCC2) genotype with pharmacokinetics of irinotecan in Japanese patients with metastatic colorectal cancer treated with irinotecan plus infusional 5-fluorouracil/leucovorin (FOLFIRI).

Fujita K, Nagashima F, Yamamoto W, Endo H, Sunakawa Y, Yamashita K, Ishida H, Mizuno K, Matsunaga M, Araki K, Tanaka R, Ichikawa W, Miya T, Narabayashi M, Akiyama Y, Kawara K, Ando Y, Sasaki Y.

Biol Pharm Bull. 2008 Nov;31(11):2137-42.

20.

Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.

Kim DW, Lee SK, Chu K, Jang IJ, Yu KS, Cho JY, Kim SJ.

Epilepsy Res. 2009 Mar;84(1):86-90. doi: 10.1016/j.eplepsyres.2008.12.001. Epub 2009 Jan 22.

PMID:
19167193
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk